clinical decision support
HIMSS25
According to Julia Zarb, Blue x Blue CEO and founder, embracing complexity, developing strong analytical skills and understanding common sensibilities and values can help newcomers succeed in the health IT field.
HIMSS25
While the First Databank's tool already delivers EHR-based clinical decision support, it now offers more personalized guidance when lab results reveal a medication-related problem, says Virginia Halsey, the company's SVP of strategy.
HIMSS25
David Lareau, Medicomp Systems' CEO and president, says 8% to 10% of AI-captured information from complex encounters may be incorrect, but that the company's tool can flag these issues for clinicians to review.
The partners will leverage real-world evidence and AI, including the ChatRWD platform, to assist with clinical decision-making and medication formulary protocols.
Despite reluctance in the past couple of years, clinician comfort with using AI tools is growing, says Etiometry President and CEO Shane Cooke, citing results of a recent AMA survey.
HIMSS24
NEI Office of Data Science and Health Informatics Associate Director Kerry Goetz discusses advancing technology in eye health as a window to overall health.
HIMSS24
Wolters Kluwer vice president of medical informatics Howard Strasberg highlights the topics he and his colleague will discuss at HIMSS24, including data transfer between EHRs and the cloud and FHIR-based clinical decision support standards.
Anna Dover, director of product management at FDB, formerly First Data Bank, says drug-related clinical decision support alerts pose challenges for prescribers and pharmacists, but technology can optimize the process through refinement.
HIMSS23
Stacey Caywood, CEO of Wolters Kluwer Health, discusses how Wolters Kluwer solutions incorporate diversity and inclusivity into the text, images and clinical support sources they provide to help clinicians meet patients’ care needs.
HIMSS23
Digital therapeutics improve access to care, but face reimbursement challenges. Jessica Hauflaire, COO of the Digital Therapeutics Alliance, describes the DTA's work with CMS and policymakers to gain support for this new care model.